Back to results
US 2010/0061999 A1Published application
Antihuman tnf-alpha antibody activity lowering inhibitor
AssigneeAjinomoto Co., Inc.
InventorTakayuki Matsumoto
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeAjinomoto Co., Inc.
InventorTakayuki Matsumoto
Estimating the term…
The present invention provides an antihuman TNF-α antibody activity lowering inhibitor comprising a protein source(s) and/or carbohydrate source(s), in the treatment of inflammatory bowel syndrome with repeated administration of anti-TNF-α antibody; and a kit preparation wherein a freeze-dried antihuman TNF-α antibody and the activity lowering inhibitor in the above repeated administration of the anti-TNF-α antibody are separately contained in a plastic container so that they can communicate with each other. According to the present invention, in the drug therapy to the patients with inflammatory bowel syndrome, therapeutic agents which inhibit the inflammation for long periods without accompanying serious side effects can be provided.
An antihuman TNF-α antibody activity lowering inhibitor comprising a protein source(s), carbohydrate source(s) or a combination thereof, in the treatment of inflammatory bowel syndrome with repeated administration of anti-TNF-α antibody.
An immune deterioration inhibitor and/or infection preventing agent in the repeated administration of the anti-TNF-α antibody, which comprises a protein source(s) and/or carbohydrate source(s) in the treatment of inflammatory bowel syndrome with the antihuman TNF-α antibody.
Dependencies are inferred from the claim text.